Planet 13 Holdings (PLNH) Cash & Equivalents (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Cash & Equivalents came in at $6.0 million in Q1 2026, down 61.39% year-on-year from $15.6 million in Q1 2025, and up 12.81% on a QoQ basis from $5.3 million in Q4 2025.
Planet 13 Holdings (PLNH) Cash & Equivalents (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Cash & Equivalents data on file, last reported at $6.0 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 61.39% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 61.39% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, down 77.23% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $6.0 million, up from $5.3 million in the prior quarter.
- Over the last five years, Cash & Equivalents for PLNH reached as high as $62.1 million in Q1 2022 and fell as low as $5.3 million in Q4 2025.
- Historically, Cash & Equivalents has averaged $25.9 million across 5 years, with a median of $23.4 million in 2024.
- Across the five-year window, Cash & Equivalents soared 37349.39% in 2022 and plunged 77.23% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $38.8 million in 2022, then plunged by 69.5% to $11.8 million in 2023, then surged by 97.65% to $23.4 million in 2024, then plunged by 77.23% to $5.3 million in 2025, then rose by 12.81% to $6.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $6.0 million in Q1 2026, $5.3 million in Q4 2025, and $17.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.28 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 6.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.01 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 17.18 Mn |
| Jun 30, 2025 | 15.85 Mn |
| Mar 31, 2025 | 15.56 Mn |
| Dec 31, 2024 | 23.38 Mn |
| Sep 30, 2024 | 27.41 Mn |
| Jun 30, 2024 | 26.67 Mn |
| Mar 31, 2024 | 20.77 Mn |
| Dec 31, 2023 | 11.83 Mn |
| Sep 30, 2023 | 15.09 Mn |
| Jun 30, 2023 | 24.46 Mn |
| Mar 31, 2023 | 26.92 Mn |
| Dec 31, 2022 | 38.79 Mn |
| Sep 30, 2022 | 50.88 Mn |
| Jun 30, 2022 | 52.62 Mn |
| Mar 31, 2022 | 62.14 Mn |
| Dec 31, 2021 | 58.59 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 136.29 Mn |